Suppr超能文献

西诺沙星在人体中的药理学。

Pharmacology of cinoxacin in humans.

作者信息

Black H R, Israel K S, Wolen R L, Brier G L, Obermeyer B D, Ziege E A, Wolny J D

出版信息

Antimicrob Agents Chemother. 1979 Feb;15(2):165-70. doi: 10.1128/AAC.15.2.165.

Abstract

Cinoxacin was almost completely absorbed when given orally and was found to be approximately 60 to 70% protein bound. Peak serum concentrations were reached within 2 h, and detectable serum concentrations persisted up to 12 h after administration of 0.25-, 0.5-, and 1-g multiple oral doses. Although food delayed the absorption and caused a 30% reduction in mean peak serum concentrations, the overall 24-h urinary recovery was not significantly altered. Approximately 50 to 55% of the drug was excreted in the urine as unchanged drug. At 12 h, urine concentrations were still above the minimal inhibitory concentration for most common gram-negative urinary pathogens. Cinoxacin was well tolerated when administered to 23 volunteers from 10 to 28 days. Resistance among fecal isolates initially susceptible to cinoxacin was not observed in nine volunteers who were administered 0.5 g every 12 h for 4 to 28 days.

摘要

环丙沙星口服后几乎完全被吸收,发现其蛋白结合率约为60%至70%。口服0.25克、0.5克和1克多次剂量后,2小时内达到血清峰值浓度,给药后12小时内仍可检测到血清浓度。尽管食物会延迟吸收并导致平均血清峰值浓度降低30%,但24小时的总体尿液回收率没有显著变化。约50%至55%的药物以原形经尿液排泄。12小时时,尿液浓度仍高于大多数常见革兰氏阴性尿路病原体的最低抑菌浓度。对23名志愿者给药10至28天,环丙沙星耐受性良好。在每12小时服用0.5克、持续4至28天的9名志愿者中,未观察到最初对环丙沙星敏感的粪便分离株产生耐药性。

相似文献

1
Pharmacology of cinoxacin in humans.
Antimicrob Agents Chemother. 1979 Feb;15(2):165-70. doi: 10.1128/AAC.15.2.165.
2
Influence of probenecid on serum levels and urinary excretion of cinoxacin.
Antimicrob Agents Chemother. 1979 Mar;15(3):465-9. doi: 10.1128/AAC.15.3.465.
3
Cinoxacin concentrations in plasma, urine and prostatic tissue after oral administration to man.
Br J Urol. 1977 Apr;49(2):147-52. doi: 10.1111/j.1464-410x.1977.tb04089.x.
4
Influence of urinary pH on the pharmacokinetics of cinoxacin in humans and on antibacterial activity in vitro.
Antimicrob Agents Chemother. 1982 Mar;21(3):472-80. doi: 10.1128/AAC.21.3.472.
5
Cinoxacin: in vitro antibacterial studies of a new synthetic organic acid.
Antimicrob Agents Chemother. 1975 Feb;7(2):159-63. doi: 10.1128/AAC.7.2.159.
6
Cinoxacin: pharmacokinetics and tolerance in patients with normal and impaired renal function.
Antimicrob Agents Chemother. 1979 Sep;16(3):411-6. doi: 10.1128/AAC.16.3.411.
7
In vitro antimicrobial activity of cinoxacin against 2,968 clinical bacterial isolates.
Antimicrob Agents Chemother. 1976 Jul;10(1):146-9. doi: 10.1128/AAC.10.1.146.
8
Microcalorimetric investigation of the action of cinoxacin against Escherichia coli.
J Antimicrob Chemother. 1978 Jan;4(1):73-8. doi: 10.1093/jac/4.1.73.
9
Comparative pharmacokinetic profiles of cinoxacin and pipemidic acid in humans.
Eur J Drug Metab Pharmacokinet. 1983 Jul-Sep;8(3):251-9. doi: 10.1007/BF03188755.
10
Cinoxacin: pharmacokinetics and the effect of probenecid.
J Clin Pharmacol. 1978 Oct;18(10):491-9. doi: 10.1002/j.1552-4604.1978.tb01577.x.

引用本文的文献

1
Together or Apart? Revealing the Impact of Dietary Interventions on Bioavailability of Quinolones: A Systematic Review with Meta-analyses.
Clin Pharmacokinet. 2024 Jun;63(6):773-818. doi: 10.1007/s40262-024-01377-0. Epub 2024 May 28.
2
Influence of urinary pH on the pharmacokinetics of cinoxacin in humans and on antibacterial activity in vitro.
Antimicrob Agents Chemother. 1982 Mar;21(3):472-80. doi: 10.1128/AAC.21.3.472.
3
Comparative pharmacokinetic profiles of cinoxacin and pipemidic acid in humans.
Eur J Drug Metab Pharmacokinet. 1983 Jul-Sep;8(3):251-9. doi: 10.1007/BF03188755.
6
Pharmacokinetics: metabolism and renal excretion of quinolones in man.
Pharm Weekbl Sci. 1986 Feb 21;8(1):29-34. doi: 10.1007/BF01975476.
8
Cinoxacin: pharmacokinetics and tolerance in patients with normal and impaired renal function.
Antimicrob Agents Chemother. 1979 Sep;16(3):411-6. doi: 10.1128/AAC.16.3.411.

本文引用的文献

3
Compound 64716, a new synthetic antibacterial agent.
Antimicrob Agents Chemother. 1973 Oct;4(4):415-20. doi: 10.1128/AAC.4.4.415.
4
Serum protein binding of the aminoglycoside antibiotics.
Antimicrob Agents Chemother. 1972 Sep;2(3):214-6. doi: 10.1128/AAC.2.3.214.
5
Efficacy of cinoxacin in urinary tract infections.
Antimicrob Agents Chemother. 1976 Mar;9(3):502-5. doi: 10.1128/AAC.9.3.502.
6
In vitro activity of cinoxacin, an organic acid antibacterial.
Antimicrob Agents Chemother. 1975 Mar;7(3):370-3. doi: 10.1128/AAC.7.3.370.
7
Antibacterial activity of cinoxacin in vitro.
Antimicrob Agents Chemother. 1975 May;7(5):688-92. doi: 10.1128/AAC.7.5.688.
8
Cinoxacin: in vitro antibacterial studies of a new synthetic organic acid.
Antimicrob Agents Chemother. 1975 Feb;7(2):159-63. doi: 10.1128/AAC.7.2.159.
9
In vitro antimicrobial activity of cinoxacin against 2,968 clinical bacterial isolates.
Antimicrob Agents Chemother. 1976 Jul;10(1):146-9. doi: 10.1128/AAC.10.1.146.
10
Management of simple ureterolithotomy closure.
Urology. 1977 Oct;10(4):310-1. doi: 10.1016/0090-4295(77)90156-x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验